Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
11/2013
11/13/2013CN103387560A Preparation method of 2-[(4R, 6S)-6-substitued methyl-2, 2-dimethyl-1, 3-dioxan]-acetate
11/13/2013CN102272115B Glycol compound having dioxane structure and manufacturing method therefor
11/12/2013US8580979 Method of preparing a humic acid extraction
11/06/2013CN102391243B Preparation method of atorvastatin intermediate (3R, 5S)-7-amino-3,5-O-isopropylidene-3,5-dyhydroxyl heptylic acid tert-butyl acetate
11/05/2013US8575367 Ketal ester derivatives
11/05/2013US8574456 Liquid-crystalline medium and liquid crystal display
10/2013
10/31/2013WO2013160485A1 Process for continuous preparation of lactide directly from concentrated lactic acid
10/31/2013WO2013160418A1 Novel compounds
10/30/2013CN103373897A Preparation method of trifluorostyrene compound
10/30/2013CN102633767B Preparation method of non-ionic type iodine contrast medium intermediate 2-isopropyl-5-carboxy-1, 3-dioxane
10/30/2013CN101497596B Method for synthesizing diethyleno dioxide
10/29/2013US8569518 Bicyclic dioxanes, their preparation and their use as fragrant compounds
10/29/2013US8569517 Cleaning device for separating dilactide from mixtures, polymerisation device, method for separating dilactide from mixtures and use thereof
10/24/2013WO2013158302A1 Derivatives of docosahexaenoylethanolamide and uses thereof
10/24/2013WO2013157528A1 Bicyclic compound
10/24/2013WO2013130792A3 Prodrugs of fluorinated mevalonates to inhibit the mevalonate pathway of streptococcus pneumoniae
10/24/2013US20130281486 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous system diseases
10/23/2013CN103370312A 1,3-dioxan-5-one compounds
10/23/2013CN103360362A Method of preparing lactide from lactate
10/22/2013US8563753 Microencapsulated catalyst
10/16/2013CN103351275A Liquid crystal compound including polyfluoroindan, composition thereof and application
10/10/2013WO2013150457A1 Fuel compositions comprising hydrophobic derivatives of glycerine
10/10/2013US20130267716 Method of preparing lactide from lactate
10/10/2013US20130267561 Substituted 1,3-Dioxanes Useful as PPAR Modulators
10/10/2013US20130267538 Treatment of mitochondrial diseases
10/09/2013CN103342693A Preparation method of trans-2(4-hologenated-3-fluorophenyl)-5-alkyl-[1,3] dioxane
10/09/2013CN101891733B Catalyst for direct conversion of esters of lactic acid to lactide and the method for producing lactide using the same
10/09/2013CN101633654B Ring carbonic ester monomer containing acrylate class functional group as well as preparation and application thereof
10/08/2013US8552209 Recovery of lactic acid values from a meso-lactide stream
10/08/2013US8552066 Modified chalcone compounds as antimitotic agents
10/08/2013US8551982 Benzodioxane inhibitors of leukotriene production
10/03/2013US20130261316 Neprilysin inhibitors
10/02/2013CN103333155A Liquid-crystal compound containing 1,4-dioxo-six-membered ring as well as preparation method and application thereof
09/2013
09/26/2013WO2013140969A1 Photoresist composition, compound and method for producing same
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013US20130253045 Prodrugs of Substituted 1,3-Dioxanes and Their Uses
09/25/2013CN103328458A Liquid-crystalline compounds and liquid-crystalline media
09/25/2013CN102344434B Method for preparing difluorobenzene derivatives
09/24/2013US8541611 Bifunctional phenyl iso(thio)cyanates, processes and intermediates products for their preparation
09/24/2013US8541605 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses
09/19/2013US20130245284 Prodrugs of Fluorinated Mevalonates to Inhibit the Mevalonate Pathway of Streptococcus pneumoniae
09/18/2013EP2638037A2 Polyhydroxy ketal ester adducts, methods of manufacture and uses thereof
09/12/2013WO2013134226A1 Benzodioxanes for inhibiting leukotriene production
09/12/2013WO2013133377A1 Method for producing lactide
09/12/2013WO2013131901A1 Benzodioxanes in combination with other actives for inhibiting leukotriene production
09/12/2013US20130237701 Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates
09/11/2013CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases
09/11/2013CN102382098B Bruguiera gymnorrhiza 5 (BG5) as well as preparation method and application thereof
09/11/2013CN102123996B Method of obtaining lactide
09/06/2013WO2013130792A2 Prodrugs of fluorinated mevalonates to inhibit the mevalonate pathway of streptococcus pneumoniae
09/04/2013CN102532502B Biological functionalization degradable polyester and preparation method thereof
09/04/2013CN101889006B Intermediates and methods for making zearalenone macrolide analogs
09/03/2013US8524766 Modulators of dopamine neurotransmission
08/2013
08/29/2013US20130225787 Process for manufacturing lactic acid
08/29/2013US20130225573 Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
08/29/2013US20130224137 Skin lightening compositions
08/29/2013DE102012202782A1 Neue Oxidationsfarbstoffvorprodukte Last oxidation dye precursors
08/28/2013CN103265688A Preparation method of glycolic acid polymer
08/28/2013CN103265524A Preparation method of beta-amino-2,5-dioxane lactone derivatives
08/28/2013CN102796072B Alizarin dioxane derivatives, and preparation method and application thereof
08/28/2013CN102190625B Stilbene tumor targeted medicine Combretastatin A4 analogs
08/28/2013CN102180862B Method for preparing (4R-cis)-6-substituted-2,2-dimethyl-1,3-dioxane-4-tert-butyl acetate
08/22/2013WO2013123222A1 Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds
08/22/2013WO2013121209A1 Novel cyclic phenoxy compounds and improved treatments for cardiac and cardiovascular disease
08/22/2013US20130217899 Intermediate compounds and process for the preparation of fingolimod
08/22/2013US20130217879 Entecavir synthesis method and intermediate compound thereof
08/21/2013CN103254095A Separating and purifying method in iobitridol preparation process
08/21/2013CN101203500B Substituted arylamine compounds and uses as 5-HT6 moderator thereof
08/20/2013CA2723302C Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
08/15/2013US20130209392 Heteroatom containing cyclic dimers
08/14/2013EP2625168A1 Phenyl diamides and a pharmaceutical preparation comprising phenyl diamides
08/14/2013CN1974550B Process for the preparation of compounds having CF2O bridge
08/14/2013CN103242287A Preparation method of glycolide
08/14/2013CN103240033A Easily separated degradable sodium carboxylate surfactant and preparation and performance thereof
08/14/2013CN102276576B Benzamide compound and preparation method thereof
08/14/2013CN101555243B Manufacturing method and device of cyclic refined lactic acid dimmer and manufacturing method and device of polylactic acid
08/07/2013CN101331114B 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
08/01/2013US20130197243 Salts of 7-amino-3,5-dihydroxyheptanoic acid esters
08/01/2013US20130197030 Substituted 1,3-Dioxanes and There Uses
08/01/2013US20130196973 Benzodioxane inhibitors of leukotriene production
08/01/2013US20130195954 Films and particles
07/2013
07/31/2013CN103224484A Preparation method of 2-((4R, 6S)-6-chloromethyl-2-alkyl-1,3-dioxane -4-yl)acetic acid
07/31/2013CN102020628B Improved method of preparation process of polylactic acid midbody lactide
07/30/2013CA2676444C Prodrugs of substituted 1,3-dioxanes and their uses
07/25/2013WO2013108514A1 Production method for cyclopentanone derivative, intermediate compound, and production method for intermediate compound
07/25/2013US20130190407 Calcium receptor-active molecules
07/24/2013EP2616455A1 Lacylate synthesis methods using dilactides
07/24/2013EP2616454A1 Esters of hexanoic acids as intermediates for the preparation of atorvastatin
07/24/2013EP2616440A1 Arylosulfonamides for the treatment of cns diseases
07/24/2013CN103214327A Aromatic ring or heteroaromatic trifluoromethyl ketone compound and preparation method thereof
07/24/2013CN102351838B Synthetic method of 1,4-dioxane-2,5-diol
07/24/2013CN102198388B Method and device for synthesizing compound by solid phase reaction
07/24/2013CN101918387B Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same
07/23/2013US8492562 (Meth)acrylate derivative, intermediate thereof, and polymer compound
07/23/2013US8492372 Modulators of dopamine neurotransmission
07/23/2013CA2542695C Substituted benzylaminoalkylene heterocycles
07/18/2013US20130184222 Therapeutically active compositions and their methods of use
07/17/2013EP2614057A1 Salts of 7-amino-3,5-dihydroxyheptanoic acid esters
07/17/2013CN103209973A Lacylate synthesis methods using dilactides
07/16/2013US8486994 Prodrugs of substituted 1,3-dioxanes and their uses
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 103